Resources

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: June 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: June 15, 2021

COVID-19 and Education Disruption in Ontario: Emerging Evidence on Impacts

Product: — Science Table

About Coronavirus Public Health Policy Public Policy & Economic Impact School Protocols Schools & Learning

covid19-sciencetable.ca Last Updated: June 4, 2021

Response to the Premier of Ontario

Product: — Science Table

Community & Social Services Future Planning Public Health & Implementation Public Health Policy Public Policy & Economic Impact

covid19-sciencetable.ca Last Updated: May 29, 2021

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Product: — Cochrane Library

Drug Interventions Immune System Treatments Vaccines & Immunity

www.cochranelibrary.com Last Updated: May 20, 2021

Also available in Français

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: May 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Lay Summary

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 7, 2021